EFM
E Fund Management’s Cogent Biosciences COGT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.3K | Sell |
10,205
-5,465
| -35% | -$39.2K | ﹤0.01% | 382 |
|
|
2025
Q1 | $93.9K | Buy |
15,670
+4,290
| +38% | +$25.7K | ﹤0.01% | 384 |
|
|
2024
Q4 | $88.8K | Buy |
+11,380
| New | +$88.8K | ﹤0.01% | 381 |
|
|
2024
Q3 | – | Sell |
-11,173
| Closed | -$94.2K | – | 359 |
|
|
2024
Q2 | $94.2K | Sell |
11,173
-22,135
| -66% | -$187K | 0.01% | 305 |
|
|
2024
Q1 | $224K | Buy |
33,308
+17,897
| +116% | +$120K | 0.01% | 324 |
|
|
2023
Q4 | $90.6K | Buy |
+15,411
| New | +$90.6K | 0.01% | 304 |
|
|
2023
Q3 | – | Sell |
-11,088
| Closed | -$131K | – | 299 |
|
|
2023
Q2 | $131K | Sell |
11,088
-2,661
| -19% | -$31.4K | 0.01% | 292 |
|
|
2023
Q1 | $148K | Sell |
13,749
-3,226
| -19% | -$34.7K | 0.01% | 311 |
|
|
2022
Q4 | $196K | Buy |
16,975
+2,585
| +18% | +$29.8K | 0.02% | 306 |
|
|
2022
Q3 | $215K | Buy |
+14,390
| New | +$215K | 0.02% | 294 |
|